FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

212611000001100: Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1865641000001118 Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1865651000001115 Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Nabumetone false Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Nabumetone true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Is pack of False Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has AMP True Nabumetone 500mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start